Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Scientific Reports
|
March 25, 2016
Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
Xingming Zhang, Pengfei Shen, Qiying He, et al.
Oncology Research
|
July 7, 2023
Mutations in epigenetic regulator <i>KMT2C</i> detected by liquid biopsy are associated with worse survival in prostate cancer patients
Sha Zhu, Nanwei Xu, Jiayu Liang, et al.
Urologic Oncology
|
October 15, 2018
What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis
Guangxi Sun, Xingming Zhang, Junru Chen, et al.
American Journal of Translational Research
|
October 12, 2020
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma
Xiaoxue Yin, Xingming Zhang, Zhenhua Liu, et al.
BMC Cancer
|
April 18, 2019
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
Xingming Zhang, Xiaoxue Yin, Haoran Zhang, et al.
Japanese Journal of Clinical Oncology
|
July 29, 2020
The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
Xingming Zhang, Haoran Zhang, Jindong Dai, et al.
Cancer Treatment Reviews
|
June 21, 2024
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Yaowen Zhang, Junru Chen, Haoyang Liu, et al.
The Prostate
|
March 4, 2025
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
Yifu Shi, Xinyuan Wei, Fengnian Zhao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 14, 2023
AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
Linmao Zheng, Xingming Zhang, Xiuyi Pan, et al.
Cancer Management and Research
|
September 13, 2021
Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma
Xudong Zhu, Xingming Zhang, Guangxi Sun, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Scientific Reports
|
March 25, 2016
Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
Xingming Zhang, Pengfei Shen, Qiying He, et al.
Oncology Research
|
July 7, 2023
Mutations in epigenetic regulator <i>KMT2C</i> detected by liquid biopsy are associated with worse survival in prostate cancer patients
Sha Zhu, Nanwei Xu, Jiayu Liang, et al.
Urologic Oncology
|
October 15, 2018
What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysis
Guangxi Sun, Xingming Zhang, Junru Chen, et al.
American Journal of Translational Research
|
October 12, 2020
Assessment for prognostic value of differentially expressed genes in immune microenvironment of clear cell renal cell carcinoma
Xiaoxue Yin, Xingming Zhang, Zhenhua Liu, et al.
BMC Cancer
|
April 18, 2019
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
Xingming Zhang, Xiaoxue Yin, Haoran Zhang, et al.
Japanese Journal of Clinical Oncology
|
July 29, 2020
The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
Xingming Zhang, Haoran Zhang, Jindong Dai, et al.
Cancer Treatment Reviews
|
June 21, 2024
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Yaowen Zhang, Junru Chen, Haoyang Liu, et al.
The Prostate
|
March 4, 2025
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
Yifu Shi, Xinyuan Wei, Fengnian Zhao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 14, 2023
AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
Linmao Zheng, Xingming Zhang, Xiuyi Pan, et al.
Cancer Management and Research
|
September 13, 2021
Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma
Xudong Zhu, Xingming Zhang, Guangxi Sun, et al.
Page
of 13